What does Almirall do?
Almirall is a global pharmaceutical company focused on the research, development, and commercialization of innovative medicines, particularly in the fields of dermatology and immunology. The company aims to improve patients' quality of life by providing effective treatments for chronic and serious conditions. Almirall is committed to advancing healthcare through science and technology.
- Sectors
- Wholesalers
- Signals
-
ProfitableProfitable € 171K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 3.94MStrong equity provides a buffer against setbacks.
Low riskLow risk 62.6%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 2.60A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 200KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 277KPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 9.51MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 22.1%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|
|
€
9.51M
|
€
7.50M
|
|
|
€
277K
|
€
236K
|
|
|
€
171K
|
€
122K
|
|
|
€
3.94M
|
€
3.64M
|
|
|
62.61%
|
66.70%
|
|
|
€
2.35M
|
€
1.82M
|
|
|
€
6
|
€
3.29M
|
|
|
15
|
11.80
|
Publications 118
All publications- Ontslagen - Benoemingen 06/10/2026
- Ontslagen - Benoemingen 11/02/2026
- Ontslagen - Benoemingen 01/12/2025
- Ontslagen - Benoemingen 23/05/2025
- Diversen 02/08/2024
Frequently asked questions
Answers to the most common questions about Almirall, based on official government data and the filed annual accounts.
What is the VAT number of Almirall?
The VAT number of Almirall is BE0403.090.131.
How many employees work at Almirall?
In 2024, Almirall employed 15.00 full-time equivalents (FTE).
When was Almirall established?
Almirall was founded in 01-01-1968.
What is the official address of Almirall?
The official address of Almirall is Lenneke Marelaan 4 Zaventem 1932.
What is the legal form of Almirall?
The juridical form of Almirall is Public limited company (NV/SA).
What is the annual revenue of Almirall?
The revenue of Almirall for the 2024 financial year was €9,514,021.
What does Almirall do?
Almirall is a global pharmaceutical company focused on the research, development, and commercialization of innovative medicines, particularly in the fields of dermatology and immunology. The company aims to improve patients' quality of life by providing effective treatments for chronic and serious conditions. Almirall is committed to advancing healthcare through science and technology.
Is Almirall a reliable company?
Almirall is a registered Rechtspersoon with company number 0403.090.131 and can be verified through the official CBE database.
What is the credit limit of Almirall?
The estimated credit limit of Almirall is €925,298.
Is Almirall still active?
Almirall currently has the status "Normal situation" and is active.